Lupus

Procalcitonin > 0.9 ng/mL can be a critical marker for identifying bacterial infection in #SLE. Single center study of 116 juv. SLE pts dx bacterial infx in 17%. Procalcitonin was signif better than others: NLR, PLR, ESR, CRP, LC4R, ferritin (cut offs need to be defined) https://t.co/gJ6CbEUW0I
Dr. John Cush @RheumNow( View Tweet )
Tuesday Night Rheumatology returns this month with the launch of Lupus Unlocked, starting with a special Journal Club session. Join authors Dr. Richard Furie and Dr. Brad Rovin as they walk us through their pivotal studies on lupus nephritis: 📄 Obinutuzumab in Active Lupus https://t.co/PdhC857sfX
Dr. John Cush @RheumNow( View Tweet )
RheumNow Podcast square

Keys to Mastery (5.2.2025)

Jack Cush, MD

Dr. Jack Cush reviews the news, articles and drug approvals from the past week on RheumNow.com. This podcast marks the beginning of our Lupus Campaign called "Lupus Unlocked: Keys to Mastery". This month's campaign on Lupus is sponsored by Aurinia.

Read Article
lupus_0.jpg

Secondary Benefits to SGLT2 Inhibitor Use in SLE

Jack Cush, MD

An emulation trial of sodium–glucose cotransporter 2 inhibitors (SGLT2i) in systemic lupus erythematosus patients yielded a significantly reduced risk of several cardiorenal complications among patients with SLE and type 2 diabetes.

Read Article
45 southern African American SLE pts compared to multiethnic cSLE, AA pts had signif higher Dz activity & greater damage accrual. Their mean SLICC score was 8.4, SLEDAI 13, but was 7.4 @6 mos & 4,7 @1 yr. They traveled an avg distance 75 miles to see Rheum https://t.co/NMlT4uo8jn https://t.co/uG5ofMGE6O

Links:

Dr. John Cush @RheumNow( View Tweet )
Procalcitonin > 0.9 ng/mL can be a critical marker for identifying bacterial infection in #SLE. Single center study of 116 juv. SLE pts dx bacterial infx in 17%. Procalcitonin was signif better than others: NLR, PLR, ESR, CRP, LC4R, ferritin (cut offs need to be defined) https://t.co/3ujTDIucFM
Dr. John Cush @RheumNow( View Tweet )
Tuesday Night Rheumatology returns this month with the launch of Lupus Unlocked, starting with a special Journal Club session. Join authors Dr. Richard Furie and Dr. Brad Rovin as they walk us through their pivotal studies on lupus nephritis: 📄 Obinutuzumab in Active Lupus https://t.co/2zZOEzsnnI
Dr. John Cush @RheumNow( View Tweet )
variety of contraception methods

Contraception in SLE

Lisa Sammaritano MD

Pregnancy in SLE gets a lot of press in the rheumatology literature, and deservedly so, since pregnancy risks can be markedly increased. It was not that many years ago that women with SLE were counseled to avoid pregnancy. As recently as 2004, the maternal mortality rate in SLE was 20-fold

Read Article
RHEUMATOLOGIST SURVEY: Which Lupus patients should undergo renal Bx?

Dr. John Cush @RheumNow( View Tweet )

🔓 Unlock the latest in lupus care! RheumNow presents Lupus Unlocked – Keys to Mastery, a month-long dive into clinical insights and expert perspectives. KOL videos & articles Tuesday Nite Rheumatology Webinars Weekly Podcasts Surveys + Downloadable Slides 📅 Launching May 1 – https://t.co/WhihzdLxIJ
Dr. John Cush @RheumNow( View Tweet )
pregnancy.sperm_.jpg

EULAR Guidelines on Reproductive Health

MedPage Today

Rheumatology patients considering or actually having babies can safely take most of the medications currently used to treat their conditions, according to an updated guideline from the European Alliance of Associations for Rheumatology (EULAR).

Read Article
RHEUMATOLOGIST SURVEY: Which Lupus patients should undergo renal Bx?

Dr. John Cush @RheumNow( View Tweet )

RHEUMATOLOGIST SURVEY: Which Lupus patients should undergo renal Bx?

Dr. John Cush @RheumNow( View Tweet )

Looking for the latest updates on treatments and disparities for patients with systemic lupus erythematosus and lupus nephritis? Join us at AWIR 2025 to learn from Maria Dall’Era, MD, Jean S. Engleman Distinguished Professor of Medicine and Chief of the Division of https://t.co/QPyojkztCj

Links:

Association of Women in Rheumatology @AWIRGROUP( View Tweet )
RHEUMATOLOGIST SURVEY: Which Lupus patients should undergo renal Bx?

Dr. John Cush @RheumNow( View Tweet )

Simplistic overview of Lupus Nephritis - causes, risk factors, symptoms, diagnosis, and treatment of lupus nephritis. https://t.co/QkLXUQcSqo https://t.co/pGjCHmoelG

Links:

Dr. John Cush @RheumNow( View Tweet )
🦋 This May, RheumNow brings you Lupus Unlocked – Keys to Mastery Your one-stop hub for lupus education: ✅ Expert KOL content ✅ Weekly webinars & podcasts ✅ Engaging surveys + slides Sponsored by Aurinia — empowering HCPs to advance care. #Lupus #Rheumatology https://t.co/rf4GveV3eh
Dr. John Cush @RheumNow( View Tweet )
RheumNow Podcast square

Rheumatology: Believe It or Not (4/25/2025)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Should we believe the reviews and metanalyses?

Read Article
Systematic review shows PTSD is strongly assoc w/ an increased risk of developing SLE. 7 studies (5 prospect cohort) and 11614 SLE pts - 1,325 (11.4%) had comorbid PTSD, mostly females. All showed + association of PTSD & SLE, 3 showing 2fold incr risk of SLE. No genetic https://t.co/Xjya0QNznQ
Dr. John Cush @RheumNow( View Tweet )
RHEUMATOLOGISTS: What is your initial steroid dosing regimen w/ Class III/IV Lupus nephritis?

Dr. John Cush @RheumNow( View Tweet )

✅ Management of #REFRACTORY skin manifestations in patients with #LUPUS ➡️ my practical tips 💪 for #PANLAR2025 🇲🇽 https://t.co/KnJO0eXI4W

Links:

Laurent ARNAUD @Lupusreference( View Tweet )
RHEUMATOLOGISTS: What is your initial steroid dosing regimen w/ Class III/IV Lupus nephritis?

Dr. John Cush @RheumNow( View Tweet )

RHEUMATOLOGISTS: Which regimen do you choose for Class V Lupus Nephritis

Dr. John Cush @RheumNow( View Tweet )

🔓 Unlock the latest in lupus care! RheumNow presents Lupus Unlocked – Keys to Mastery, a month-long dive into clinical insights and expert perspectives. KOL videos & articles Tuesday Nite Rheumatology Webinars Weekly Podcasts Surveys + Downloadable Slides 📅 Launching May 1 – https://t.co/g0NP1NZe9k
Dr. John Cush @RheumNow( View Tweet )
Should Lupus Nephritis Receive PJP Prophylaxis? A current review article suggests that the need for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in patients with systemic lupus erythematosus (SLE) and lupus nephritis will need to be individualized based on therapies and https://t.co/QGHxk3O8q4
Dr. John Cush @RheumNow( View Tweet )

Recent Blogs

Focus on the Fasting Lipid Profile

Dr Paul Anthony John Russo
Blood labs
How best do we communicate CV risk associated with RA to other members of the treating team, most particularly the primary care physicians? After some experimentation, I have come up with an approach that seems to work and which does not take up much time. Read Post

A Brief History of Rheumatoid Arthritis Mimics

Robert Schoen, MD, MBA
books history
Imagine that 100 years from now, your great granddaughter, an eminent rheumatologist, reviews the history of rheumatoid arthritis mimics. Read Post
×